Clinical Trial Update: Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing safety and potential efficacy of Iberdomide (CC-220) and CC-99282 in combination with R-CHOP for B-cell non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• CC-99282
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)
• iberdomide (iberdomide)

Snippet

Sponsor: Celgene | Conditions: Lymphoma, B-Cell | Phase 1 | Status: RECRUITING